| scholarly article | Q13442814 |
| P50 | author | Slava Epelman | Q56477231 |
| P2093 | author name string | David J Kennedy | |
| W H Wilson Tang | |||
| James D Thomas | |||
| Allen G Borowski | |||
| Kevin Shrestha | |||
| Zhili Shao | |||
| P2860 | cites work | Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia | Q57099225 |
| Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme | Q79900412 | ||
| A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 | ||
| A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 | ||
| Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism | Q24300310 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme | Q28216431 | ||
| Angiotensin-(1-7) and the renin-angiotensin system | Q28287695 | ||
| Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system | Q33799399 | ||
| Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. | Q35229766 | ||
| Angiotensin-converting enzyme 2: the first decade | Q35550937 | ||
| Angiotensin-converting enzyme II in the heart and the kidney | Q36412271 | ||
| The emerging role of ACE2 in physiology and disease | Q36804138 | ||
| Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure | Q37079211 | ||
| Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis | Q37101896 | ||
| Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions | Q39599579 | ||
| ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. | Q42514935 | ||
| Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction | Q43266255 | ||
| Myocardial infarction increases ACE2 expression in rat and humans. | Q45238600 | ||
| Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients | Q46716852 | ||
| Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP. | Q48315421 | ||
| Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts. | Q52852148 | ||
| Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. | Q54395386 | ||
| P433 | issue | 9 | |
| P921 | main subject | heart failure | Q181754 |
| acute decompensated heart failure | Q4677930 | ||
| P304 | page(s) | 605-610 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | Journal of Cardiac Failure | Q2134415 |
| P1476 | title | Increasing serum soluble angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in acute decompensated heart failure | |
| P478 | volume | 19 |
| Q35760437 | ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy |
| Q34866649 | ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury |
| Q37620934 | Angiotensin-converting enzyme 2 as a therapeutic target for heart failure |
| Q92710285 | Counter-regulatory renin-angiotensin system in cardiovascular disease |
| Q38249995 | Emerging biomarkers for heart failure: an update. |
| Q93119593 | Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease |
| Q92022823 | Soluble angiotensin converting enzyme 2 levels in chronic heart failure is associated with decreased exercise capacity and increased oxidative stress-mediated endothelial dysfunction |
| Q87461308 | Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China |
Search more.